🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Teladoc vs. Doximity: Which Telehealth Stock Is a Better Buy?

Published 07/15/2021, 01:37 PM
Updated 07/15/2021, 02:30 PM
© Reuters.  Teladoc vs. Doximity: Which Telehealth Stock Is a Better Buy?
TDOC
-

Teladoc (NYSE:TDOC) and Doximity (DOCS) are part of the high growth digital health market and have multiple secular tailwinds allowing them to improve revenue and profit margins going ahead. While Teladoc is trading at a lower valuation, Doximity is already posting an operating profit.In case you have a long-term investment horizon, you need to identify stocks that are disrupting the markets where they operate. In the last year, the ongoing pandemic disrupted several companies across industries such as airlines and hospitality. However, COVID-19 also acted as a tailwind for companies part of the e-commerce, collaboration, and digital health verticals.

Stocks such as Teladoc (TDOC) and Well Health Technologies (WLYYF) outpaced the broader markets by a significant margin in 2020. Now, the recent IPO Doximity (DOCS), which is an online networking service for medical professionals, has also attracted investors due to the rapidly expanding market for digital health platforms.

Here, we compare the growth potential between Teladoc and Doximity to analyze which is a better stock right now.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.